DOI: 10.12890/2021_002298
Treatment with Delta-9-tetrahydrocannabinol/cannabidiol in Multiple Sclerosis: Influence on the Autonomy Profile according to the International Classification of Functioning, Disability and Health
Authors
francesco.corea@uslumbria2.it
Keywords
Multiple sclerosis, ICF, neurorehabilitation, delta-9-tetrahydrocannabinol/cannabidiolAbstract
Multiple sclerosis (MS) is the most common cause of non-traumatic neurological disability in young adults. It has effects at different levels: physical, emotional, psychological, cognitive and social, with a great variety of signs and symptoms. In particular, spasticity contributes to reducing the motor performance of patients with MS, causing pain, reduction in distance walked and limitations in social life. We present the case of a 39-year-old woman with MS. She was treated with delta-9-tetrahydrocannabinol/cannabidiol and the outcome was assessed with the International Classification of Functioning Disability and Health core set framework.
References
- Wicks CR, Ward K, Stroud A, Tennant A, Ford HL . Multiple sclerosis and employment: associations of psychological factors and work instability. J Rehabil Med 2016; 48799 –805.
- WHO. International Classification of Functioning, Disability and Health. Trento: Erickson; 2002.
- Holper L, Coenen M, Weise A, Stucki G, Cieza A, Kesselring J. Characterization of functioning in multiple sclerosis using the ICF. J Neurol 2010;257(1):103–113.
- Corea F, Barbi M, Bellanti A, Ciotti S, Micheli S, Brustenghi P, et al. Analysis of activities and participation according to the International Classification of Functioning (ICF) Stroke Core Set on a cohort of ischemic stroke survivors. Cerebrovasc Dis 2014;71(Suppl): 72.
- Scarponi F, Sattin D, Leonardi M, Raggi A, Zampolini M. The description of severe traumatic brain injury in light of the ICF classification. Disabil Rehabil 2009;31(Suppl 1): S134–S143.
- Ciotti S, Bianconi F, Saraceni VM, Vulpiani MC, Rinonapoli G, Zampolini M, et al. Narrative medicine in amyotrophic lateral sclerosis and a rehabilitation project based on International Classification of Functioning, Disability and Health. Am J Phys Med Rehabil 2018;97(11):832–838.
- Coenen M, Cieza A, Freeman J, Khan F, Miller D, Weise A, et al. The development of ICF Core Sets for multiple sclerosis: results of the International Consensus Conference. J Neurol 2011;258(8):1477–1488.
- Trojano M, Bergamaschi R, Amato MP, Comi G, Ghezzi A, Lepore V, et al. The Italian MultipleSclerosis Register. Neurol Sci 2019;40(4):907.
- Carotenuto A, Costabile T, De Lucia M, Moccia M, Falco F, Petruzzo M, et al.Predictors of nabiximols (Sativex®) discontinuation over long-term follow-up: a real-life study. J Neurol 2020;267(6):1737–1743. doi: 10.1007/s00415-020-09739-x.